モデルナワクチンのアジア系への有効性100%、ファイザーは74.4%だけどソースは？
人種に関する有効性の説明
Did the vaccines help people of color?
All five of the people in the Moderna trial who developed COVID-19 after receiving the vaccine were white. As a result, the Moderna vaccine was 100% effective in Black, Latino and Asian Americans, as well as in people with mixed racial backgrounds. Vaccine efficacy could not be determined for Native Americans or Pacific Islanders because there were no cases of COVID-19 in either the vaccine or the placebo groups.
In its Phase 3 trial, the Pfizer vaccine was 100% effective for Black study participants and 94.5% effective for Latino participants, slightly below the 94.7% effectiveness for white subjects. In addition, it was 74.4% effective in Asian Americans, and 100% effective in Native Americans and Pacific Islanders. Among people described as multiracial, it was only 10.4% effective, with one case of COVID-19 among those who got the vaccine and one case among those who got the placebo.
モデルナのアジア系への有効性(100%)は記事リンク先のPDFに記載 (24P)
https://www.fda.gov/media/144434/download
ファイザーのアジア系への有効性 (74.4%)のソースが記事内には見つけられない。
ググっても見つけられていない。
有効性の判断基準が60%以上だから、74.4%でもOKなんだけど
有効性だけを見ると、アジア系としてはモデルナの方がいいと思った。
